Global Octreotide Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Report Id

46437

Publisher Name

Global Info Research

Published Date

2/21/2019

No of Pages

119

Market Scenario

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically?it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid. Scope of the Report: The production of Octreotide mainly focuses on Europe, China and India. The Europe occupies the largest share and it about reach 66.36% in 2015. Novartis exports to other countries mainly in the form of finished drug. The Octreotide product increased fast in the past five years, the production growth in the past two years. There have been new manufacturers to enter the field year by year. But for now , it is difficult to obtain certification. It will expect that the production and the capacity will increase fast in the future, But with octreotide acetate in China continues to mature in manufacturing technology, in the future, trade of octreotide API will gradually decrease, more and more Octreotide will sold as finished medicine. The worldwide market for Octreotide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Octreotide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Novartis Sun Pharmaceutical Chengdu Tiantaishan pharmaceutical Sinopharm A-Think Pharmaceuticals Sihuan Pharmaceutical Holdings Group Shanghai Soho-Yiming Pharmaceuticals Yibin Pharmaceutical Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Octreotide Injection Octreotide Powder Octreotide Microspheres Market Segment by Applications, can be divided into Treating Severe Diarrhea Treating Acromegaly Others The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Octreotide product scope, market overview, market opportunities, market driving force and market risks. Chapter 2, to profile the top manufacturers of Octreotide, with price, sales, revenue and global market share of Octreotide in 2017 and 2018. Chapter 3, the Octreotide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Octreotide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019. Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019. Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019. Chapter 12, Octreotide market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024. Chapter 13, 14 and 15, to describe Octreotide sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Table of Contents 1 Market Overview 1.1 Octreotide Introduction 1.2 Market Analysis by Type 1.2.1 Octreotide Injection 1.2.2 Octreotide Powder 1.2.3 Octreotide Microspheres 1.3 Market Analysis by Applications 1.3.1 Treating Severe Diarrhea 1.3.2 Treating Acromegaly 1.3.3 Others 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outlook (2014-2024) 1.4.2.4 Russia Market States and Outlook (2014-2024) 1.4.2.5 Italy Market States and Outlook (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2014-2024) 1.4.3.2 Japan Market States and Outlook (2014-2024) 1.4.3.3 Korea Market States and Outlook (2014-2024) 1.4.3.4 India Market States and Outlook (2014-2024) 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2014-2024) 1.4.4.2 Egypt Market States and Outlook (2014-2024) 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024) 1.4.4.4 South Africa Market States and Outlook (2014-2024) 1.4.4.5 Turkey Market States and Outlook (2014-2024) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Novartis 2.1.1 Business Overview 2.1.2 Octreotide Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Novartis Octreotide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.2 Sun Pharmaceutical 2.2.1 Business Overview 2.2.2 Octreotide Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Sun Pharmaceutical Octreotide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.3 Chengdu Tiantaishan pharmaceutical 2.3.1 Business Overview 2.3.2 Octreotide Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.4 Sinopharm A-Think Pharmaceuticals 2.4.1 Business Overview 2.4.2 Octreotide Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.5 Sihuan Pharmaceutical Holdings Group 2.5.1 Business Overview 2.5.2 Octreotide Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.6 Shanghai Soho-Yiming Pharmaceuticals 2.6.1 Business Overview 2.6.2 Octreotide Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.7 Yibin Pharmaceutical 2.7.1 Business Overview 2.7.2 Octreotide Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Yibin Pharmaceutical Octreotide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 3 Global Octreotide Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018) 3.1 Global Octreotide Sales and Market Share by Manufacturer (2017-2018) 3.2 Global Octreotide Revenue and Market Share by Manufacturer (2017-2018) 3.3 Market Concentration Rate 3.3.1 Top 3 Octreotide Manufacturer Market Share in 2018 3.3.2 Top 6 Octreotide Manufacturer Market Share in 2018 3.4 Market Competition Trend 4 Global Octreotide Market Analysis by Regions 4.1 Global Octreotide Sales, Revenue and Market Share by Regions 4.1.1 Global Octreotide Sales and Market Share by Regions (2014-2019) 4.1.2 Global Octreotide Revenue and Market Share by Regions (2014-2019) 4.2 North America Octreotide Sales and Growth Rate (2014-2019) 4.3 Europe Octreotide Sales and Growth Rate (2014-2019) 4.4 Asia-Pacific Octreotide Sales and Growth Rate (2014-2019) 4.5 South America Octreotide Sales and Growth Rate (2014-2019) 4.6 Middle East and Africa Octreotide Sales and Growth Rate (2014-2019) 5 North America Octreotide by Country 5.1 North America Octreotide Sales, Revenue and Market Share by Country 5.1.1 North America Octreotide Sales and Market Share by Country (2014-2019) 5.1.2 North America Octreotide Revenue and Market Share by Country (2014-2019) 5.2 United States Octreotide Sales and Growth Rate (2014-2019) 5.3 Canada Octreotide Sales and Growth Rate (2014-2019) 5.4 Mexico Octreotide Sales and Growth Rate (2014-2019) 6 Europe Octreotide by Country 6.1 Europe Octreotide Sales, Revenue and Market Share by Country 6.1.1 Europe Octreotide Sales and Market Share by Country (2014-2019) 6.1.2 Europe Octreotide Revenue and Market Share by Country (2014-2019) 6.2 Germany Octreotide Sales and Growth Rate (2014-2019) 6.3 UK Octreotide Sales and Growth Rate (2014-2019) 6.4 France Octreotide Sales and Growth Rate (2014-2019) 6.5 Russia Octreotide Sales and Growth Rate (2014-2019) 6.6 Italy Octreotide Sales and Growth Rate (2014-2019) 7 Asia-Pacific Octreotide by Country 7.1 Asia-Pacific Octreotide Sales, Revenue and Market Share by Country 7.1.1 Asia-Pacific Octreotide Sales and Market Share by Country (2014-2019) 7.1.2 Asia-Pacific Octreotide Revenue and Market Share by Country (2014-2019) 7.2 China Octreotide Sales and Growth Rate (2014-2019) 7.3 Japan Octreotide Sales and Growth Rate (2014-2019) 7.4 Korea Octreotide Sales and Growth Rate (2014-2019) 7.5 India Octreotide Sales and Growth Rate (2014-2019) 7.6 Southeast Asia Octreotide Sales and Growth Rate (2014-2019) 8 South America Octreotide by Country 8.1 South America Octreotide Sales, Revenue and Market Share by Country 8.1.1 South America Octreotide Sales and Market Share by Country (2014-2019) 8.1.2 South America Octreotide Revenue and Market Share by Country (2014-2019) 8.2 Brazil Octreotide Sales and Growth Rate (2014-2019) 8.3 Argentina Octreotide Sales and Growth Rate (2014-2019) 8.4 Colombia Octreotide Sales and Growth Rate (2014-2019) 9 Middle East and Africa Octreotide by Countries 9.1 Middle East and Africa Octreotide Sales, Revenue and Market Share by Country 9.1.1 Middle East and Africa Octreotide Sales and Market Share by Country (2014-2019) 9.1.2 Middle East and Africa Octreotide Revenue and Market Share by Country (2014-2019) 9.2 Saudi Arabia Octreotide Sales and Growth Rate (2014-2019) 9.3 Turkey Octreotide Sales and Growth Rate (2014-2019) 9.4 Egypt Octreotide Sales and Growth Rate (2014-2019) 9.5 Nigeria Octreotide Sales and Growth Rate (2014-2019) 9.6 South Africa Octreotide Sales and Growth Rate (2014-2019) 10 Global Octreotide Market Segment by Type 10.1 Global Octreotide Sales, Revenue and Market Share by Type (2014-2019) 10.1.1 Global Octreotide Sales and Market Share by Type (2014-2019) 10.1.2 Global Octreotide Revenue and Market Share by Type (2014-2019) 10.2 Octreotide Injection Sales Growth and Price 10.2.1 Global Octreotide Injection Sales Growth (2014-2019) 10.2.2 Global Octreotide Injection Price (2014-2019) 10.3 Octreotide Powder Sales Growth and Price 10.3.1 Global Octreotide Powder Sales Growth (2014-2019) 10.3.2 Global Octreotide Powder Price (2014-2019) 10.4 Octreotide Microspheres Sales Growth and Price 10.4.1 Global Octreotide Microspheres Sales Growth (2014-2019) 10.4.2 Global Octreotide Microspheres Price (2014-2019) 11 Global Octreotide Market Segment by Application 11.1 Global Octreotide Sales Market Share by Application (2014-2019) 11.2 Treating Severe Diarrhea Sales Growth (2014-2019) 11.3 Treating Acromegaly Sales Growth (2014-2019) 11.4 Others Sales Growth (2014-2019) 12 Octreotide Market Forecast (2019-2024) 12.1 Global Octreotide Sales, Revenue and Growth Rate (2019-2024) 12.2 Octreotide Market Forecast by Regions (2019-2024) 12.2.1 North America Octreotide Market Forecast (2019-2024) 12.2.2 Europe Octreotide Market Forecast (2019-2024) 12.2.3 Asia-Pacific Octreotide Market Forecast (2019-2024) 12.2.4 South America Octreotide Market Forecast (2019-2024) 12.2.5 Middle East and Africa Octreotide Market Forecast (2019-2024) 12.3 Octreotide Market Forecast by Type (2019-2024) 12.3.1 Global Octreotide Sales Forecast by Type (2019-2024) 12.3.2 Global Octreotide Market Share Forecast by Type (2019-2024) 12.4 Octreotide Market Forecast by Application (2019-2024) 12.4.1 Global Octreotide Sales Forecast by Application (2019-2024) 12.4.2 Global Octreotide Market Share Forecast by Application (2019-2024) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

Methodology

This research report involves complete picture of the market with the help of in-depth secondary and primary research. This research report studies several aspects of the market and analyze vital industry influencers. Extensive secondary research has been conducted using paid as well as open access data sources in order to gather information on the market and parent market. These key findings are then analyzed and validated with the help of in-house data models and primary discussions with key industry participants and experts across the value chain

research-methodology

Research Tools and Models

  • Top-Down Approach and Bottom-Up Approach
  • QFD Modeling for Market Size and Share Calculation
  • Regression, Variable and Impact Analysis
  • Penetration Modeling

Qualitative Research

  • It comprises briefing about market dynamics and business opportunities and strategies.
  • Finally, all the research findings are validated through interviews with in-house industry experts, freelance consultants and key opinion leaders etc.

Quantitative Research

It involves various mathematical tools, models, projection, and sampling techniques. It involves following steps:

  • Identification of market variables and market size derivation
  • Assessment of future prospects, opportunities and market penetration rates by analyzing product commercialization, regional trends etc.
  • Evaluation historical market trends and derivation of present and future year-on-year growth trends

Fill below details to get free sample !!

Contact Us
Call Now